ID

27690

Description

Study part: Medical History Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Keywords

  1. 11/26/17 11/26/17 -
Copyright Holder

Charité – University of medicine Berlin

Uploaded on

November 26, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Medical History Screening Day -14 to 0 SirTac NCT02936388

Medical History Screening Day -14 to 0

Allgemeine Anamnese
Description

Allgemeine Anamnese

Alias
UMLS CUI-1
C0262926
Patienten-ID:
Description

Patienten-ID

Data type

text

Alias
UMLS CUI [1]
C1269815
Schriftliche Einwilligung zur Studienteilnahme erfolgt am
Description

date informed consent

Data type

date

Alias
UMLS CUI [1]
C2985782
Primarius: Zeitpunkt der Diagnose:
Description

date diagnosis primary tumor

Data type

date

Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C0677930
Metastasierung-Zeitpunkt der Diagnose:
Description

date of diagnosis metastases

Data type

date

Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C0027627
Vortherapien:
Description

Vortherapien:

Alias
UMLS CUI-1
C1514463
Primarius
Description

Primary tumor

Data type

text

Alias
UMLS CUI [1]
C0677930
Art der Therapie
Description

Therapy

Data type

text

Alias
UMLS CUI [1]
C0087111
Metastasierung
Description

Metastases

Data type

text

Alias
UMLS CUI [1]
C0027627
Art der Therapie
Description

Therapy

Data type

text

Alias
UMLS CUI [1]
C0087111
Dauermedikation zum Zeitpunkt des Einschlusses
Description

long- term medication

Data type

boolean

Alias
UMLS CUI [1]
C0420257
Datum
Description

date

Data type

date

Alias
UMLS CUI [1]
C0011008
Name Prüfarzt
Description

investigator name

Data type

text

Alias
UMLS CUI [1]
C2826892
Unterschrift Prüfarzt
Description

investigator signature

Data type

text

Alias
UMLS CUI [1]
C2346576

Similar models

Medical History Screening Day -14 to 0

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Allgemeine Anamnese
C0262926 (UMLS CUI-1)
Patienten-ID
Item
Patienten-ID:
text
C1269815 (UMLS CUI [1])
date informed consent
Item
Schriftliche Einwilligung zur Studienteilnahme erfolgt am
date
C2985782 (UMLS CUI [1])
date diagnosis primary tumor
Item
Primarius: Zeitpunkt der Diagnose:
date
C2316983 (UMLS CUI [1,1])
C0677930 (UMLS CUI [1,2])
date of diagnosis metastases
Item
Metastasierung-Zeitpunkt der Diagnose:
date
C2316983 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Item Group
Vortherapien:
C1514463 (UMLS CUI-1)
Primary tumor
Item
Primarius
text
C0677930 (UMLS CUI [1])
Therapy
Item
Art der Therapie
text
C0087111 (UMLS CUI [1])
Metastases
Item
Metastasierung
text
C0027627 (UMLS CUI [1])
Therapy
Item
Art der Therapie
text
C0087111 (UMLS CUI [1])
long- term medication
Item
Dauermedikation zum Zeitpunkt des Einschlusses
boolean
C0420257 (UMLS CUI [1])
date
Item
Datum
date
C0011008 (UMLS CUI [1])
investigator name
Item
Name Prüfarzt
text
C2826892 (UMLS CUI [1])
investigator signature
Item
Unterschrift Prüfarzt
text
C2346576 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial